Intestinal Microbiome‐Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice-Reference-Cited by-同舟云学术

Intestinal Microbiome‐Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice

Published:2020-12 Issue:6 Volume:72 Page:2090-2108
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Isaacs‐Ten Anna¹,Echeandia Marta¹,Moreno‐Gonzalez Mar¹,Brion Arlaine²,Goldson Andrew²,Philo Mark²,Patterson Angela M.¹,Parker Aimee¹,Galduroz Mikel¹,Baker David³,Rushbrook Simon M.⁴,Hildebrand Falk¹⁵,Beraza Naiara¹⁶

Affiliation:

1. Gut Microbes and Health Institute Strategic Programme Quadram Institute Bioscience Norwich Research Park Norwich United Kingdom

2. Analytical Science Unit Quadram Institute Bioscience Norwich Research Park Norwich United Kingdom

3. Science Operations Quadram Institute Bioscience, Norwich Research Park Norwich United Kingdom

4. Department of Gastroenterology Norfolk and Norwich University Hospital Norwich United Kingdom

5. Digital Biology Earlham Institute Norwich United Kingdom

6. Food Innovation and Health Institute Strategic Programme Quadram Institute BioscienceNorwich Research Park Norwich United Kingdom

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31228

Reference49 articles.

1. Interactions between the microbiota and the immune system;Hooper LV;Science,2012

2. Human intestinal barrier function in health and disease;Konig J;Clin Transl Gastroenterol,2016

3. Cytokine regulation of tight junctions;Capaldo CT;Biochim Biophys Acta,2009

4. Age‐associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction;Thevaranjan N;Cell Host Microbe,2018

5. Control of commensal microbiota by the adaptive immune system;Zhang H;Gut Microbes,2015

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide;Gut Microbes;2024-09-12

2. Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion;Gut Microbes;2024-08-29

3. The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis;Best Practice & Research Clinical Gastroenterology;2024-08

4. Dynamic changes of gut microbiota in mouse models of metabolic dysfunction‐associated steatohepatitis and its transition to hepatocellular carcinoma;The FASEB Journal;2024-07-05

5. Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review;Food Science & Nutrition;2024-06-07